SENTRY
The National Drug
Intelligence Center (NDIC) SENTRY is an Internet-based system designed
to collect and disseminate synthetic drug-related data in order to
identify new trends at an early stage, evaluate their likely importance,
and track their development.
SENTRY focuses on synthetic drugs that
are primarily produced via a chemical process, such as LSD (lysergic
acid diethylamide), MDMA (3,4-methylenedioxymethamphetamine, also
known as ecstasy), and methamphetamine. To be truly effective as
an early warning system, however, the system also monitors prescription
drugs, over-the-counter medications, botanical substances and extracts,
and chemicals and products involved in the manufacturing of synthetic
drugs.
SENTRY is accessible at www.sentry.usdoj.gov or via the NDIC
Internet site. From the SENTRY web site, authorized users can submit
information on a new or unusual synthetic drug-related activity via
an electronic submission form, link to partner agencies and our listserv,
search and receive NDIC products, and view previously reported
submissions using the geographic
information system capabilities.
SENTRY welcomes partnerships at
multiple levels--federal, state, and
local. Current partners include the
Office of National Drug Control Policy
(ONDCP), Substance Abuse and
Mental Health Services Administration,
and National Institute on Drug
Abuse. In addition, a network of
correctional officers, drug diversion
investigators, emergency medical
personnel, forensic chemists, juvenile
detention officers, law enforcement
officers, medical toxicologists,
school nurses, school resource officers,
and treatment providers have
joined the SENTRY partnership.
NDIC uses the information obtained
through SENTRY, combines it with
additional information, and produces
and disseminates DrugAlert Watch
and DrugAlert Warning reports. A
DrugAlert Watch report is issued
when a pattern of synthetic drug-related
activity is first identified.
The DrugAlert Watch report relies
heavily on qualitative information
obtained from our wide network of
partners. Once a pattern is established,
NDIC continues collecting and
evaluating additional information.
When a trend is detected, a DrugAlert Warning report is issued.
A DrugAlert Warning report
combines the qualitative/anecdotal
data collected in the DrugAlert
Watch phase with quantitative/statistical data collected by NDIC
analysts and our partners.
SENTRY is operated by NDIC in coordination
with ONDCP and supports the
National Synthetic Drugs Action Plan.
How to Participate
To participate in SENTRY and report emerging synthetic drug-related
issues in your area, please provide the following information, typed
on your agency letterhead, and fax it to (814) 532-5858:
- Contact information including:
- First name, middle initial, last
name and title of requester
- Requestor's role within your agency (please choose only
one):
- Chemist
- Education provider (teacher, administrator, school
resource officer, school nurse)
- Law enforcement officer
- Treatment provider to include physicians specializing
in drug abuse issues
- Medical service personnel (physician, nurse, emergency
medical technician, medical examiner)
- Other, please explain
- Complete mailing address (do not use post office box numbers)
- E-mail address
- Phone number
- Fax number
- Signature of requestor
An NDIC analyst will phone you within 2 business days with your login
information.
To Top
More Information
If you have questions or comments
about SENTRY or NDIC
intelligence products, please e-mail
us at NDIC.Sentry@usdoj.gov.
For more information on NDIC or SENTRY, contact:
Collections Management Group National Drug Intelligence
Center 319 Washington Street, 5th Floor Johnstown, PA 15901-1622
Telephone: (814) 532-5888 FAX: (814) 532-5858 https://www.sentry.usdoj.gov
NDIC publications are available on the following web sites:
Internet:
www.usdoj.gov/ndic
ADNET: http://ndicosa.adnet.sgov.gov
RISS: ndic.riss.net LEO:
https://www.leo.gov/http://leowcs.leopriv.gov/lesig/ndic/index.htm
NDIC is a component of the
U.S. Department of Justice and is
located in Johnstown, Pennsylvania.
The NDIC mission is to provide
strategic drug-related intelligence
and assistance to the drug control,
public health, and national security
authorities of the United States in
order to reduce the adverse impact
of drug trafficking, drug abuse, and
related harms to the United States.
![DOJ seal.](https://webarchive.library.unt.edu/eot2008/20090813000702im_/http://justice.gov/ndic/images/dojseal.gif)
To Top
|